At J+D, it’s our mission to simplify the complex nature of pharmaceutical forecasting. We are dedicated to bringing smarter forecasting solutions to pharmaceutical and biotech companies in order to make more informed strategic and operational investment decisions for the future.
For decades, we have crafted bespoke pharmaceutical forecasting models, innovative software and interactive training solutions.
Working collaboratively with global, regional and affiliate teams and deployed our FC+ software and FC365 forecasting platform in 70+ countries.
Developed over 1000 forecast models, supporting every stage of the forecasting process, from early-stage pipeline products to on-market brands.
At J+D, we are passionate about making the forecasting process better, more rewarding and easier for everyone involved. As industry leaders, we are driving innovation within pharmaceutical forecasting and continuously developing our solutions.
Our clients’ needs are central to our services and solutions, which is why we create solutions with specific business needs in mind. We balance market complexity with easy to use yet innovative technology, underpinned with the best pharmaceutical forecasting principles.
We combine proven techniques with innovative approaches, and are experts in all pharmaceutical forecasting methodologies, with advanced experience in process and change management.
Our team of experts have decades of experience in the pharmaceutical industry, We incorporate our knowledge and extensive experience with innovative technology to make the forecasting process more accurate, transparent, and efficient.
A multi-disciplinary team who understand all aspects of pharma forecasting. We offer real experts, solving real forecasting challenges, when you need them.
Technology enables us to automate much of the forecasting process to bring efficiencies for our clients. In-house development means we can quickly adopt the latest technology into our solutions.
J+D were approached by a global pharmaceutical company with a broad pipeline across rare diseases, who needed an improved forecasting approach to evaluate a new extension line in greater detail and gain valuable insight from affiliates.
J+D were approached by a global pharmaceutical company who needed a new forecasting solution with a robust process management system to give them a solid foundation when forecasting their pipeline assets.
The adoption of Onco+ has helped this biotech cut the forecast development pipeline significantly and supported best practice forecasting within their team.
